These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37193052)

  • 21. Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity.
    Jia R; Zhang J; Bertagnin C; Cherukupalli S; Ai W; Ding X; Li Z; Zhang J; Ju H; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2021 Feb; 212():113097. PubMed ID: 33385836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.
    Järhult JD; Muradrasoli S; Wahlgren J; Söderström H; Orozovic G; Gunnarsson G; Bröjer C; Latorre-Margalef N; Fick J; Grabic R; Lennerstrand J; Waldenström J; Lundkvist A; Olsen B
    PLoS One; 2011; 6(9):e24742. PubMed ID: 21931841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
    Guo L; Garten RJ; Foust AS; Sessions WM; Okomo-Adhiambo M; Gubareva LV; Klimov AI; Xu X
    Antiviral Res; 2009 Apr; 82(1):29-33. PubMed ID: 19428592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties.
    Jia R; Zhang J; Shi F; Bonomini A; Lucca C; Bertagnin C; Zhang J; Liu C; Jia H; Jiang Y; Ma X; Loregian A; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2023 Apr; 252():115275. PubMed ID: 36931117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic.
    Zhang W; Xu H; Guan S; Wang C; Dong G
    J Med Virol; 2022 Sep; 94(9):4406-4416. PubMed ID: 35585032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K; Sharma S; Dash PK; Parida M
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance.
    McKimm-Breschkin JL
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):25-36. PubMed ID: 23279894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.
    Wong DD; Choy KT; Chan RW; Sia SF; Chiu HP; Cheung PP; Chan MC; Peiris JS; Yen HL
    J Virol; 2012 Oct; 86(19):10558-70. PubMed ID: 22811535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Emergence of Oseltamivir-Resistant Seasonal Influenza A (H1N1) Virus in Korea During the 2008-2009 Season.
    Choi WY; Yang I; Kim S; Lee N; Kwon M; Lee JY; Kang C
    Osong Public Health Res Perspect; 2011 Dec; 2(3):178-85. PubMed ID: 24159470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
    Gubareva LV; Trujillo AA; Okomo-Adhiambo M; Mishin VP; Deyde VM; Sleeman K; Nguyen HT; Sheu TG; Garten RJ; Shaw MW; Fry AM; Klimov AI
    Antivir Ther; 2010; 15(8):1151-9. PubMed ID: 21149922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.
    Wang Y; Wu D; Yu D; Wang Z; Tian L; Wang Y; Han W; Fang X
    J Mol Model; 2012 Aug; 18(8):3445-53. PubMed ID: 22278046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of potential drugs for human-infecting H7N9 virus containing R294K mutation.
    He JY; Li C; Wu G
    Drug Des Devel Ther; 2014; 8():2377-90. PubMed ID: 25489236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral Activity of Benzoic Acid Derivative NC-5 Against Influenza A Virus and Its Neuraminidase Inhibition.
    Guo M; Ni J; Yu J; Jin J; Ma L; Zhang H; Wang D; Zhang X; Dou J; Zhou C
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31842256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
    Hurt AC; Holien JK; Parker MW; Barr IG
    Drugs; 2009; 69(18):2523-31. PubMed ID: 19943705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.